In this episode of BioTales, we uncover the remarkable story of Skyhawk Therapeutics – a biotech company with its wings firmly set on the frontiers of RNA biology. From a chance meeting on a humanitarian trip that sparked a revolutionary vision, to billion‑dollar collaborations with pharma giants, Skyhawk’s journey reads like a biotech thriller. We dive into the science of RNA splicing, the trials of launching a startup, and the promise of first‑in‑class, orally available medicines for Huntin...
All content for BioTales - Every Biotech Has a Story is the property of Hurley Li and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of BioTales, we uncover the remarkable story of Skyhawk Therapeutics – a biotech company with its wings firmly set on the frontiers of RNA biology. From a chance meeting on a humanitarian trip that sparked a revolutionary vision, to billion‑dollar collaborations with pharma giants, Skyhawk’s journey reads like a biotech thriller. We dive into the science of RNA splicing, the trials of launching a startup, and the promise of first‑in‑class, orally available medicines for Huntin...
Holding Cancer Hostage: The Revolutionary Science Behind Halda Therapeutics and RIPTACs
BioTales - Every Biotech Has a Story
19 minutes
2 months ago
Holding Cancer Hostage: The Revolutionary Science Behind Halda Therapeutics and RIPTACs
This episode tells the extraordinary story of Halda Therapeutics, founded during the 2020 pandemic when renowned Yale professor Craig Crews gathered his team around an outdoor fireplace to brainstorm revolutionary cancer treatments. We explore Crews' journey as a serial biotech entrepreneur and his pioneering RIPTACs (Regulated Induced Proximity TArgeting Chimeras) at Halda -- a groundbreaking "hold and kill" approach that doesn't destroy cancer proteins but holds them hostage instead. The ep...
BioTales - Every Biotech Has a Story
In this episode of BioTales, we uncover the remarkable story of Skyhawk Therapeutics – a biotech company with its wings firmly set on the frontiers of RNA biology. From a chance meeting on a humanitarian trip that sparked a revolutionary vision, to billion‑dollar collaborations with pharma giants, Skyhawk’s journey reads like a biotech thriller. We dive into the science of RNA splicing, the trials of launching a startup, and the promise of first‑in‑class, orally available medicines for Huntin...
